205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-9.93%
Negative revenue growth while MU stands at 0.89%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-29.32%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
89.00%
Positive EBIT growth while MU is negative. John Neff might see a substantial edge in operational management.
89.00%
Positive operating income growth while MU is negative. John Neff might view this as a competitive edge in operations.
103.86%
Positive net income growth while MU is negative. John Neff might see a big relative performance advantage.
105.56%
Positive EPS growth while MU is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
105.56%
Positive diluted EPS growth while MU is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.07%
Slight or no buybacks while MU is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.33%
Slight or no buyback while MU is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-3.01%
Dividend reduction while MU stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-109.49%
Negative OCF growth while MU is at 13.16%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-487.33%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
20.18%
10Y revenue/share CAGR under 50% of MU's 1654.86%. Michael Burry would suspect a lasting competitive disadvantage.
8.64%
5Y revenue/share CAGR under 50% of MU's 770.61%. Michael Burry would suspect a significant competitive gap or product weakness.
-27.24%
Negative 3Y CAGR while MU stands at 131.46%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
-140.49%
Negative 5Y OCF/share CAGR while MU is at 793.46%. Joel Greenblatt would question the firm’s operational model or cost structure.
-118.39%
Negative 3Y OCF/share CAGR while MU stands at 4.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-89.63%
Negative 10Y net income/share CAGR while MU is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-87.29%
Negative 5Y net income/share CAGR while MU is 324.80%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-95.45%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
176.77%
Below 50% of MU's 567.74%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
73.88%
Below 50% of MU's 210.83%. Michael Burry suspects a serious short-term disadvantage in building book value.
88.03%
Dividend/share CAGR of 88.03% while MU is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
40.38%
Dividend/share CAGR of 40.38% while MU is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
36.61%
Our short-term dividend growth is positive while MU cut theirs. John Neff views it as a comparative advantage in shareholder returns.
-2.29%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
4.58%
Inventory growth well above MU's 5.99%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-4.42%
Negative asset growth while MU invests at 1.06%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.99%
Under 50% of MU's 36.35%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-3.24%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-55.74%
Our R&D shrinks while MU invests at 2.57%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-10.57%
We cut SG&A while MU invests at 28.08%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.